Here’s some troubling news from the Wall Street Journal :
In a striking shift, Pfizer Inc. will abandon efforts to develop medicines for heart disease, as part of a broad research reshuffling it announced Tuesday.
Pfizer will be leaving a field that includes its cholesterol-lowering drug Lipitor and other medicines that fueled the company’s dominance of the pharmaceutical industry for more than a decade.
The beleaguered New York pharmaceutical giant also is exiting therapies for obesity and bone health, to focus on more-profitable areas, such as cancer.
Of course, increasing efforts to find treatments and cures for cancer is a good thing. But I wish we didn’t have to stop developing medicines for America’s number one killer in order to do so.
The Possibility of Possibility
"Might could” is a Southern expression meaning “maybe I could” or “I might be able to,” conveying…
The False Promise of No Contact
Around the time nineteen-year-old Alice began cutting ties with her family, she announced on social media that…
Moral Certitude and the Iran War
The current military engagement with Iran calls renewed attention to just war theory in the Catholic tradition.…